[ABMD] ABIOMED, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization: 5.06 B

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 112.38 Change: 0.83 (0.74%)
Ext. hours: Change: 0 (0%)

chart ABMD

Refresh chart

Strongest Trends Summary For ABMD

ABMD is in the long-term up 2899% in 9 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart fai

Fundamental Ratios
Shares Outstanding42.99 M EPS1.16 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 38.41% Sales Growth - Q/Q8.95% P/E123.61
P/E To EPS Growth P/S21.98 P/BV17.37 Price/Cash Per Share38.37
Price/Free Cash Flow132.89 ROA33.6% ROE38.99% ROI
Current Ratio5.6 Quick Ratio5.17 Long Term Debt/Equity Debt Ratio0.13
Gross Margin82.66% Operating Margin12.45% Net Profit Margin49.36% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities9.52 M Cash From Investing Activities-49.86 M Cash From Operating Activities43.29 M Gross Profit56.75 M
Net Profit98.87 M Operating Profit12.36 M Total Assets338.37 M Total Current Assets220.14 M
Total Current Liabilities39.32 M Total Debt Total Liabilities46.81 M Total Revenue67.56 M
Technical Data
High 52 week418.21 Low 52 week137.43 Last close418.21 Last change2.06%
RSI74.47 Average true range12.71 Beta1.13 Volume141.67 K
Simple moving average 20 days6.46% Simple moving average 50 days21.82% Simple moving average 200 days72.66%
Performance Data
Performance Week3.05% Performance Month13.37% Performance Quart41.89% Performance Half122.56%
Performance Year196.12% Performance Year-to-date123.15% Volatility daily1.43% Volatility weekly3.2%
Volatility monthly6.56% Volatility yearly22.72% Relative Volume291.59% Average Volume752.5 K
New High New Low

News

2019-03-19 17:50:09 | Abiomed ABMD Gains As Market Dips: What You Should Know

2019-03-19 12:21:04 | Boston Scientific BSX Rides on Acquisitions, Innovation

2019-03-19 12:19:04 | Boston Scientific's EP Arm Gets a Lift From Study Success

2019-03-19 11:42:03 | Abbott's ABT MitraClip COAPT Trial Shows Favorable Results

2019-03-19 10:56:02 | Here's Why You Should Invest in Integer Holdings ITGR Stock

2019-03-19 09:35:01 | HealthEquity HQY Earnings & Revenues Beat Estimates in Q4

2019-03-18 11:17:03 | Allscripts Partners With Opargo to Boost Practice Management

2019-03-18 11:14:03 | Omnicell's Global Expansion on Track, Stiff Competition Ails

2019-03-18 09:30:01 | Is ABIOMED ABMD Outperforming Other Medical Stocks This Year?

2019-03-18 08:51:12 | BioScrip BIOS Reports Loss in Q4, Both Margins Contract

2019-03-18 07:00:00 | Impella RP Post-Approval Study Data Presented at ACC 2019

2019-03-15 15:26:07 | Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg

2019-03-15 11:01:03 | Integra's Duragen Secures Japanese Nod to Drive Global Growth

2019-03-15 10:02:02 | Abbott ABT Gets FDA Approval for Expanded Use of MitraClip

2019-03-14 15:32:07 | Allscripts Strengthens Strategic Relationship with Pulse8

2019-03-14 09:36:01 | Tandem Diabetes TNDM Hits a 52-Week High on Solid Prospects

2019-03-14 09:12:01 | Cardiovascular Systems Gains on Global Growth & Innovation

2019-03-14 08:00:00 | Benefits of Heart Recovery with Impella Showcased at ACC 2019

2019-03-13 12:41:04 | Here's Why Investors Should Retain McKesson MCK Stock Now

2019-03-13 10:55:02 | 10 Stocks Powering S&P 500 ETF in the 10-Year Bull Run

2019-03-13 09:58:01 | Allscripts to Fortify Middle East Foothold With New Project

2019-03-12 17:50:09 | Abiomed ABMD Outpaces Stock Market Gains: What You Should Know

2019-03-12 11:27:03 | Here's Why Investors Should Bet on Cooper Companies COO Now

2019-03-12 10:26:33 | See what the IHS Markit Score report has to say about Abiomed Inc.

2019-03-12 09:37:01 | Haemonetics' Plasma Unit Grows, Global Expansion on Track

2019-03-12 09:24:01 | Hill-Rom's Buyout of Voalte to Bolster Digital Connectivity

2019-03-12 07:00:11 | The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

2019-03-11 14:52:06 | GNC Holdings Global Business Strong, Domestic Sales Weak

2019-03-11 14:25:06 | Tandem Diabetes Signs as an Insulin Pump Vendor in Canada

2019-03-11 09:32:01 | Does ABIOMED, Inc.’s NASDAQ:ABMD CEO Pay Matter?

2019-03-11 09:19:01 | The Best And Worst Stocks of the 10-Year Bull Market

2019-03-11 09:16:01 | Invitae NVTA Scales a New 52-Week High on Solid Prospects

2019-03-08 16:33:15 | Why Shockwave Medical jumped nearly 86% in its first two days on Wall Street

2019-03-08 09:50:02 | ResMed's New Brightree Suite to Boost Home Infusion Business

2019-03-08 09:10:02 | Here's Why Investors Should Bet on Merit Medical MMSI Now

2019-03-08 08:56:01 | Resmed RMD to Acquire HB Healthcare to Treat Sleep Apnea

2019-03-07 16:52:24 | Shockwave Medical IPO Soars On First Day Of Trading

2019-03-07 09:11:45 | The bull market is almost 10 – here are some facts and figures

2019-03-07 08:33:01 | Baxter BAX Gets FDA Approval for Eptifibatide to Treat ACS

2019-03-07 08:25:01 | Cooper Companies COO Hits 52-Week High on Solid Prospects

2019-03-06 10:30:03 | Align Technology Teen Case Growth High, Competition Lingers

2019-03-06 08:22:01 | GNC Holdings' GNC Q4 Earnings Miss Estimates, Margins Fall

2019-03-05 09:50:02 | Here's Why You Should Invest in AngioDynamics Stock Now

2019-03-05 08:51:01 | Walgreens Boots Rides on Retail Pharmacy USA, Strategic Deals

2019-03-05 08:41:01 | Henry Schien Buys North American Rescue, Expands Medical Arm

2019-03-05 07:35:12 | Quest Diagnostics Ties Up With RMC to Deliver Lab Services

2019-03-04 09:36:02 | Medtronic's Mazor Robotics Aid Growth, Rising Costs Ail

2019-03-04 08:33:01 | Medtronic Launches Grafton DBM Bone Grafting Product in Japan

2019-03-01 07:53:12 | Medtronic Gets FDA Approval for Accurian RF Ablation Platform

2019-02-28 09:47:02 | Integra Rides on Channel Expansion Strategy, New Alliances